Telenostic

Telenostic: A global technology company based in Ireland, Telenostic is dedicated to pioneering digital parasitology diagnostic solutions. The company's flagship product, OvaCyte™, represents a breakthrough in parasite egg recovery and identification, revolutionizing intestinal parasite analysis at the point of care. Telenostic's innovative approach leverages superior technology and Artificial Intelligence-driven data to provide more efficient and cost-effective diagnostics for veterinarians and other industry professionals. Founded in 2016, Telenostic has emerged as a leader in the digital parasitology arena, committed to advancing next-generation platform devices that promise to shape the future of multiple industries. The company's vision prioritizes smarter, more efficient, and cost-effective methods for diagnosing intestinal parasite infections in both animals and humans. With an unwavering dedication to research and development, Telenostic has positioned itself as a frontrunner in digital parasitology, offering solutions that meet the evolving needs of the healthcare and veterinary sectors.

With its slogan "For Targeted treatment," Telenostic encapsulates its commitment to providing tailored diagnostic solutions that enhance precision and efficacy in treating parasite infections. As the company continues to expand its reach and influence within the industry, Telenostic's dedication to innovation and technological advancement underscores its potential for long-term success and impact.